Raghuvanshi Exports

12 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• ALLERGEN8 refused lines

  Major food allergen not declared

  The label appeared not to declare all major food allergens present in the product, as section 403(w) of the FD&C Act requires.

• LIST INGRE2 refused lines

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• FILTHY1 refused line

  Filthy, putrid or decomposed substance

  The product appeared to consist in whole or in part of a filthy, putrid, or decomposed substance, or to be otherwise unfit for food.

Questions about Raghuvanshi Exports

Is Raghuvanshi Exports on an FDA import alert?

Yes. As of October 26, 2026, Raghuvanshi Exports is on the red list of FDA Import Alert 99-22, “Undeclared or mislabeled major food allergens”, for fried poha chiwda; FDA published the listing on May 21, 2019.

Has FDA refused shipments from Raghuvanshi Exports?

Yes. FDA refused 9 shipment lines from Raghuvanshi Exports between October 31, 2019 and March 17, 2025. The most recent, on March 17, 2025, was snack foods not elsewhere mentioned, n.e.c., charged as ALLERGEN (major food allergen not declared).

Why did FDA refuse Raghuvanshi Exports's shipments?

The most frequent charges are ALLERGEN (major food allergen not declared, 8 lines) and LIST INGRE (ingredients not listed, 2 lines).

When was Raghuvanshi Exports last inspected by FDA?

FDA's most recent inspection of Raghuvanshi Exports with a final classification is dated May 5, 2014 and was classified VAI (Voluntary Action Indicated).

What is Raghuvanshi Exports's FEI number?

Raghuvanshi Exports's FDA Establishment Identifier (FEI) is 3009934097.

Can shipments from Raghuvanshi Exports still enter the U.S.?

Shipments of fried poha chiwda from Raghuvanshi Exports can be detained without physical examination under Import Alert 99-22; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).